U.S. Handheld Echocardiography Devices Market: Portability Transforming Cardiac Diagnostics
The U.S. handheld echocardiography devices market is undergoing a quiet but significant transformation in the way heart conditions are diagnosed. Once confined to bulky cart-based systems in hospital radiology departments, echocardiography is now shifting toward compact, pocket-sized devices that connect directly to smartphones and tablets. This evolution is not just a matter of convenience — it is reshaping how quickly and widely clinicians can detect cardiovascular disease, particularly in emergency and point-of-care settings.
Market Size and Growth Trajectory
The numbers tell a compelling growth story. The U.S. handheld echocardiography devices market size was valued at USD 21.6 million in 2022 and is projected to grow from USD 23.9 million in 2023 to USD 52.6 million by 2030, registering a CAGR of 11.9% during the forecast period, according to Fortune Business Insight. This more than doubling of market value within less than a decade underscores both the clinical need for rapid cardiac diagnostics and the pace at which device manufacturers are innovating to meet that demand.
Why Portability Matters
Traditional echocardiography has long relied on cart-based and portable systems housed in hospitals and radiology centers. While effective, these systems are not always practical in time-sensitive or resource-constrained environments. Handheld devices solve this problem by allowing the echocardiography probe to connect directly to a mobile phone or tablet, letting clinicians visualize cardiac images almost instantly, according to Fortune Business Insight. Compared to their cart-based counterparts, these devices are far more portable and come with user-friendly controls, making them especially valuable in emergency departments, ambulances, and remote clinics where speed of diagnosis can be a matter of life and death.
Driving Factors Behind Market Growth
Rising Burden of Cardiovascular Disease
The single biggest force propelling this market is the sheer prevalence of heart disease across the United States. About 805,000 people in the U.S. suffer a heart attack every year, according to CDC data cited by Fortune Business Insight. This staggering figure has heightened public awareness around the importance of routine screening and early diagnosis, pushing healthcare providers to adopt faster, more accessible diagnostic tools. Further compounding this trend, around 47.0% of Americans have at least one of the three major risk factors for heart disease — high blood pressure, high cholesterol, or smoking — according to Fortune Business Insight. With such a large portion of the population at risk, the case for widespread, rapid screening tools like handheld echocardiography devices becomes increasingly urgent.
Emergency Care Adoption
Handheld devices have found a particularly strong foothold in emergency care settings, where speed and portability are paramount. In 2020, there were 131 million emergency department visits in the U.S., according to Fortune Business Insight. Given that cardiac assessment is a routine part of emergency triage, the ability to perform rapid, accurate echocardiograms at the bedside — without transporting patients to radiology — has made handheld devices indispensable in high-pressure clinical environments.
The COVID-19 Effect
The COVID-19 pandemic initially disrupted the market due to supply chain issues and a decline in non-emergency hospital visits. However, it also revealed the unique strengths of handheld devices. As per NCBI data, 677 COVID-19 patients admitted to the ICU underwent echocardiograms, with roughly one-third yielding abnormal results, according to Fortune Business Insight. This reinforced the value of portable cardiac imaging in intensive care settings, where traditional equipment can be cumbersome. Post-pandemic recovery has been robust, with major players like GE Healthcare recording ultrasound portfolio revenue growth of 20.6% and 7.9% in 2021 and 2022, respectively, according to Fortune Business Insight.
Artificial Intelligence Integration
A major trend reshaping the competitive landscape is the integration of artificial intelligence into handheld ultrasound devices. Given the shortage of skilled technicians trained specifically on handheld echocardiography equipment, AI-powered guidance systems — offered by companies such as Caption Health, UltraSight, and DESKi — are helping bridge this skills gap by providing real-time instructional support to nurses and less-experienced users, according to Fortune Business Insight.
Market Segmentation
The market is segmented by test type, technology, and end-user. By test type, transthoracic echocardiography dominates, driven by its effectiveness in detecting coronary artery disease; notably, about 20.1 million adults aged 20 and older had Coronary Artery Disease in 2020, according to Fortune Business Insight. By technology, the market splits into 2D and Doppler imaging, with 2D currently holding the larger share, while Doppler is expected to grow faster due to its superior imaging accuracy. By end-user, hospitals and ambulatory surgical centers (ASCs) lead the market, reflecting the sheer scale of the U.S. hospital network and its emphasis on advanced diagnostic adoption.
Restraining Factors
Despite strong momentum, the market faces technical limitations. Current handheld devices, including Lumify and Vscan Air, lack 3D and 4D imaging capabilities, offering only 2D and Doppler imaging, according to Fortune Business Insight. This restricts their clinical use largely to screening purposes, with conventional echocardiography still required for confirmatory diagnosis — a limitation that tempers, but does not derail, overall market expansion.
Competitive Landscape
The market is led by established names including Koninklijke Philips N.V., Butterfly Network, Inc., and GE Healthcare, alongside active innovators like Clarius and CHISON Medical Technologies. Recent developments reflect this competitive intensity, including Clarius’s April 2023 launch of AI-powered voice control features and GE Healthcare’s 2021 introduction of the pocket-sized Vscan Air device, according to Fortune Business Insight.
Looking Ahead
With a healthcare system increasingly oriented toward point-of-care diagnostics and early intervention, the U.S. handheld echocardiography devices market is well-positioned for sustained growth through 2030. As AI integration deepens and device capabilities expand, handheld echocardiography is likely to move from a supplementary screening tool toward a more central role in everyday cardiac care.
What’s Driving Japan’s Market? Discover the Latest “Handheld Echocardiography Devices” Insights